Syncromune, Inc. — Form D/A

Syncromune, Inc. of FORT LAUDERDALE, FL, a company, filed a Form D amendment with the SEC on 2026-05-11. The offering totals $144.8M, of which $144.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Jeffrey L. ClelandRelated PersonFort Lauderdale, FL
STEPHEN DALERelated PersonFort Lauderdale, FL
Agustin GagoRelated PersonFort Lauderdale, FL
Joseph GerardiRelated PersonFort Lauderdale, FL
Eamonn HobbsRelated PersonFort Lauderdale, FL
Charles J. LinkRelated PersonFort Lauderdale, FL
Joseph C. MaroonRelated PersonFort Lauderdale, FL
Kerri-Ann MillarRelated PersonFort Lauderdale, FL
Norman SchwartzRelated PersonFort Lauderdale, FL
Douglas G. WatsonRelated PersonFort Lauderdale, FL
Jeffrey J KrawsExecutive OfficerRockville, MD
Norman L SchwartzDirectorFort Lauderdale, FL
Eamonn J HobbsDirectorFort Lauderdale, FL
Eamonn J HobbsExecutive OfficerFort Lauderdale, FL
Jeffrey L ClelandDirectorFort Lauderdale, FL
Charles J LinkDirectorFort Lauderdale, FL
Charles J LinkExecutive OfficerFort Lauderdale, FL
Kerri-Ann L MillarExecutive OfficerFort Lauderdale, FL
Agustin J GagoExecutive OfficerFort Lauderdale, FL
Joseph J GerardiExecutive OfficerFort Lauderdale, FL
Douglas G WatsonDirectorFort Lauderdale, FL
Joseph C MaroonDirectorFort Lauderdale, FL
Gregory J ChampionExecutive OfficerFort Lauderdale, FL

Other filings by this issuer (4)

FiledFormOfferingSold
2025-08-21D/A$144.8M$111.8M
2024-12-17D$144.8M$50.8M
2023-10-06D/A$20.0M$14.2M
2022-11-29D$20.0M$5.3M

More